ArticleBioengineering (Basel, Switzerland)2025
Disease-Specific Prediction of Missense Variant Pathogenicity with DNA Language Models and Graph Neural Networks.
Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate prediction of the impact of genetic variants on human health is of paramount importance to clinical genetics and precision medicine. Recent machine learning (ML) studies have tried to predict variant pathogenicity with different levels of success. However, most missense variants identified on a clinical basis are still classified as variants of uncertain significance (VUS). Our approach allows for the interpretation of a variant for a specific disease and, thus, for the integration of disease-specific domain knowledge. We utilize a comprehensive knowledge graph, with 11 types of interconnected biomedical entities at diverse biomolecular and clinical levels, to classify missense variants from ClinVar. We use BioBERT to generate embeddings of biomedical features for each node in the graph, as well as DNA language models to embed variant features directly from genomic sequence. Next, we train a two-stage architecture consisting of a graph convolutional neural network to encode biological relationships. A neural network is then used as the classifier to predict disease-specific pathogenicity of variants, essentially predicting edges between variant and disease nodes. We compare performance across different versions of our model, obtaining prediction-balanced accuracies as high as 85.6% (sensitivity: 90.5%; NPV: 89.8%) and discuss how our work can inform future studies in this area.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.